Skip to main content

Usana Health Sciences Value Stock - Dividend - Research Selection

Usana health sciences

ISIN: US90328M1071 , WKN: 923145

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

General

 

USANA Health Sciences, Inc., a Utah corporation, was founded in 1992 by Myron W. Wentz, Ph.D. We develop and manufacture high-quality, science-based nutritional and personal care products with a primary focus on promoting long-term health and reducing the risk of chronic degenerative disease. In so doing, we are committed to continuous product innovation and sound scientific research. We have operations in 19 markets worldwide, where we distribute and sell our products by way of direct selling. We have chosen this distribution method as we believe it is the most conducive to meeting our vision as a company, which is improving the overall health and nutrition of individuals and families around the world. Our net sales in fiscal year 2014 were $790.5 million, of which 81.8% were in markets outside of the United States. As a U.S.-based multi-national company with an expanding international presence, our operating results are sensitive to currency fluctuations, as well as economic and political conditions in markets throughout the world. Additionally, we are subject to the various laws and regulations in the United States, China, and the other markets in which we operate with respect to the products that we sell and to our method of distribution.

 

Our customer base comprises two types of customers: "Associates" and "Preferred Customers." Associates share in our company vision by acting as independent distributors of our products in addition to purchasing our products for their personal use. Preferred Customers purchase our products strictly for personal use and are not permitted to resell or to distribute the products. As of January 3, 2015, we had 349,000 active Associates and 81,000 active Preferred Customers worldwide.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


USANA Health Sciences: How The Restructuring Plan Makes It A Strong Buy

2026-06-18
See more on USANA’s restructuring, Rise Wellness’ margin reset, and Hiya’s CAC headwinds—plus a USNA Buy call with $30.8 target and valuation upside.

3 Profitable Stocks with Open Questions

2026-06-04
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

USANA Earns Dual Best of State Honors for Product Innovation and Development

2026-06-04
USANA, a leader in global nutrition, earned two Best of State awards in Salt Lake City, Utah, recognizing its CellSentials supplements and Research and Development team.

1 Stock Under $50 with Promising Prospects and 2 We Brush Off

2026-06-01
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

Kevin Guest Encourages Professionals to Prioritize Wellness During Professional Wellness Month

2026-06-01
As Professional Wellness Month begins in June, Kevin Guest, Chairman and CEO of USANA Health Sciences (NYSE: USNA), is encouraging professionals, leaders, and organizations to make wellness a priority both at work and at home. He says healthier habits create stronger people, stronger teams, and stronger communities.

Should Value Investors Buy USANA Health Sciences (USNA) Stock?

2026-05-25
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

4 Top Value Stocks to Buy Now as Wall Street Takes Fresh Notice

2026-05-22
Four low P/CF value picks, Nexa Resources, Avnet, Strategic Education and USANA Health, screened for discount valuations and strong trading volume.

5 Revealing Analyst Questions From USANA’s Q1 Earnings Call

2026-05-15
USANA’s first quarter saw steady performance, with revenue flat year-over-year and a positive market reaction following results that surpassed Wall Street expectations. Management credited sequential improvements in their core nutritional business to active customer growth, particularly in China, and highlighted the impact of new product launches and investments in technology modernization. CEO Kevin Guest emphasized, “Our first quarter results reflect USANA’s continued and deliberate transforma

USNA or SDZNY: Which Is the Better Value Stock Right Now?

2026-05-12
USNA vs. SDZNY: Which Stock Is the Better Value Option?

USANA Health (USNA) Upgraded to Buy: What Does It Mean for the Stock?

2026-05-08
USANA Health (USNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.